Prudential Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Prudential Financial's XBI Position: Q2 2025 in Review
Prudential Financial sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 2,495 shares — an estimated $202K sold.
Prudential Financial first reported a position in XBI in Q1 2020 and held it in 21 quarters. The position peaked at $2.44M in Q3 2024. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.
- Prudential Financial reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
- Prudential Financial sold 2,495 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $202K.
- Prudential Financial first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and held it in 21 quarters.
- Prudential Financial's State Street SPDR S&P Biotech ETF position peaked at $2.44M in Q3 2024.
- 625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.
Based on Prudential Financial's 13F filing for Q2 2025, filed 12 Aug 2025.